CorMedix Company Insiders

CorMedix Management Team Effectiveness

The company has return on total asset (ROA) of 0.1569 % which means that it generated a profit of $0.1569 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.7508 %, meaning that it created $0.7508 on every $100 dollars invested by stockholders. CorMedix's management efficiency ratios could be used to measure how well CorMedix manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.14. In addition to that, Return On Capital Employed is expected to decline to -0.32. At present, CorMedix's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 99.6 K, whereas Return On Tangible Assets are projected to grow to (0.14). The current year's Common Stock Shares Outstanding is expected to grow to about 71.1 M, whereas Net Loss is forecasted to decline to (28.1 M). CorMedix holds a total of 78.79 Million outstanding shares. Over half of CorMedix's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as CorMedix in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of CorMedix, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

CorMedix Workforce Comparison

The company has Profit Margin (PM) of 0.76 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.49 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.49.

CorMedix Insider Trading History

CorMedix Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as CorMedix often depends on how effective the management is. CorMedix management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CorMedix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CorMedix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of CorMedix's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CorMedix's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CorMedix's management manipulating its earnings.

When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.